ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Respiratory Tract Infections
Virus Diseases

COVID-19 trials near Durham, NC, USA:

SPI-1005 Treatment in Moderate COVID-19 Patients

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Durham, North Carolina, United States and 6 other locations

multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...

Invitation-only
Covid19
Corona Virus Infection
Drug: Ebselen
Drug: Placebo

Phase 2

Sound Pharmaceuticals

Durham, North Carolina, United States and 6 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Durham, North Carolina, United States and 144 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Durham, North Carolina, United States and 66 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Chapel Hill, North Carolina, United States and 75 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Active, not recruiting
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 3

BioNTech
BioNTech

Durham, North Carolina, United States and 100 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Durham, North Carolina, United States and 149 other locations

against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a li...

Enrolling
Covid19
Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops
Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops

Phase 1

Meissa Vaccines

Raleigh, North Carolina, United States and 1 other location

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

Durham, North Carolina, United States and 199 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

Raleigh, North Carolina, United States and 90 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems